Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
'Converging' Evidence of Link Between Air Pollution and Breast Cancer
2.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
3.
Prostate cancer Q&A: Improving detection and reducing overtreatment
4.
New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.
5.
Cancer patients want financial screening early in care, study finds
1.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
2.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
3.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
4.
Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits
5.
The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation